MedPath

KRN-7000

Generic Name
KRN-7000
Drug Type
Small Molecule
Chemical Formula
C50H99NO9
CAS Number
158021-47-7
Unique Ingredient Identifier
WX671898JF

Overview

KRN7000 has been used in trials studying the treatment of Lung Cancer, Chronic Hepatitis C, Hepatitis B, Chronic, Unspecified Adult Solid Tumor, Protocol Specific, and Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT.

Background

KRN7000 has been used in trials studying the treatment of Lung Cancer, Chronic Hepatitis C, Hepatitis B, Chronic, Unspecified Adult Solid Tumor, Protocol Specific, and Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Haplo Peripheral Blood Sct In GVHD Prevention
Phase 1
Active, not recruiting
Posted: 2020/07/16
Sponsor:
Zachariah Michael De...
ID:NCT04473911
RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Cell Transplantation
Phase 2
Completed
Posted: 2019/07/10
Sponsor:
Regimmune Corporatio...
ID:NCT04014790
Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)
Phase 1
Completed
Posted: 2011/06/23
Sponsor:
Regimmune Corporatio...
ID:NCT01379209
KRN7000 in Chronic Hepatitis B
Phase 1
Completed
Posted: 2006/08/15
Sponsor:
Foundation for Liver...
ID:NCT00363155
Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection
Phase 1
Completed
Posted: 2006/07/14
Sponsor:
Foundation for Liver...
ID:NCT00352235

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy